Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Interleukins Produced in Response to Infection by Parasitic Worms Protect the Body from Autoimmune Attack

By LabMedica International staff writers
Posted on 08 Aug 2012
A recent paper discussed the molecular basis for the lower incidence of type I diabetes in developing countries caused by intestinal worm infections.

Chronic intestinal worm infections are known to blunt the effect of the self-aggressive T-cells that cause diabetes and other autoimmune diseases. More...
To determine which molecular signals trigger this loss of autoimmune activity investigators at the University of Medicine and Dentistry of New Jersey (Newark, USA) infected nonobese diabetic (NOD) mice with the strictly enteric nematode parasite, Heligmosomoides polygyrus and then evaluated the types of cytokines produced by these animals.

They reported in the July 18, 2012, online edition of the journal Mucosal Immunology that two weeks of infection with H. polygyrus (which was then cured using oral drugs) induced T-cells to produce the cytokines interleukin (IL)-4 and IL-10, which acted independently to block T-cell autoimmune activity and provide lasting protection against development of type I diabetes. Blockade of IL-10 signaling in some mice during this short interval eliminated the protective effects of the worm infection and resulted in pancreatic beta-cell destruction and ultimately type I diabetes.

These results outline potential mechanisms to explain the potency of parasite-induced control of inflammatory diseases. Follow-up clinical studies are using eggs from another parasitic worm, Trichuris suis, to treat patients with Crohn’s disease and multiple sclerosis.

Related Links:
University of Medicine and Dentistry of New Jersey




Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.